Low-value Care

Five years after treating its first patient, Mayo Clinic leads the world in proton beam treatment

Abstract: “We’ve been led down this primrose path of medicine before. Where’s the data? Where are the randomized controlled trials?” said Brownlee, who is a leader of the national health care advocacy nonprofit Lown Institute. “You started building before you had the data.” “Mayo clearly has confidence in this machine. They want to get ahead of the game and they want to command market share,” she said. “There are so many ways $100 million could have been spent, if they cared about the health of their community.”

Publication: Post Bulletin

Date Published: November 22, 2020

Author(s): Jeff Kiger

View This Resource

To eliminate medication overload, serious cultural, educational, and policy changes are needed. This action plan offers recommendations for policymakers, health care institutions, clinicians, and patients across five key categories to reduce harm from multiple medication use. Suggested Citation: Eliminating medication overload: A national action plan. Working Group on Medication Overload. Brookline, MA: The Lown Institute, 2020. DOI: https://doi.org/10.46241/LI.YLBW4885

Pharmaceutical marketing is a significant factor in the growing public health crisis of medication overload, which puts millions of older adults at risk of preventable harm and premature death. This issue brief provides recommendations to reduce pharmaceutical industry influence by limiting pharma sales rep visits to clinicians and direct-to-consumer advertising.

This issue brief provides recommendations for clinical practice guidelines and electronic health records that would give clinicians the information they need to appropriately prescribe and deprescribe.